About KHK Pharma
KHK Pharma offers products and services including Tablets and Capsules.
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Legal Name Khk Pharmaceuticals Pvt. Ltd
- Date of Incorporation 14 May, 2015
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹47.2 Lakh
FY 2023 · +183% YoY
- Net Profit₹60,262
FY 2023 · 1% margin
- EBITDA₹81,435
FY 2023 · 2% margin
Associated legal entities of KHK Pharma
KHK Pharma operates through Khk Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Khk Pharmaceuticals Private Limited CIN U24100DL2015PTC280163 | Active | 14 May 2015 | New Delhi, Delhi | ₹0.5 Cr | – | 3 | View details |
Products & Services of KHK Pharma
KHK Pharma offers a comprehensive portfolio of products and services, including Tablets and Capsules.
Tablets such as Aceclofenac and Paracetamol are manufactured and supplied for medical applications.
Capsules are produced and distributed as part of various dosage forms to address healthcare requirements.
Board of directors of Khk Pharmaceuticals Private Limited (KHK Pharma)
Khk Pharmaceuticals Private Limited is the primary company behind KHK Pharma. The board of Khk Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Nayeem Ahmad Siddiqui, appointed in 2015. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nayeem Ahmad Siddiqui DIN 02772643 | Director | 14 May 2015 | 11 yrs 4 mo | Khk Pharmaceuticals Private Limited |
| Moiz Ahmad DIN 07122224 | Director | 14 May 2015 | 11 yrs 4 mo | Khk Pharmaceuticals Private Limited |
| Sohail Abbas DIN 08306842 | Director | 12 Jan 2019 | 7 yrs 8 mo | Khk Pharmaceuticals Private Limited |
Financials of KHK Pharma
Figures of Khk Pharmaceuticals Private Limited, the primary company behind KHK Pharma, for FY 2023. Revenue was ₹47.2 Lakh (+183% year on year). Net profit was ₹60,262 (1% margin). EBITDA was ₹81,435 (2% margin). Revenue has grown at a compounded annual rate of +76% over three years and +47% over five years.
- ₹47.2 LakhRevenue · FY 2023 · +183% YoY
- ₹60,262Net profit · 1% margin
- ₹81,435EBITDA · 2% margin
- ₹1 LakhPaid-up capital
- +76%Revenue CAGR, 3 years
- +47%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Khk Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for KHK Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to KHK Pharma
10 companies that operate in the same segment as KHK Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about KHK Pharma
The primary company behind KHK Pharma, Khk Pharmaceuticals Private Limited, reported revenue of ₹47.2 Lakh for FY 2023, up 183% year on year.
KHK Pharma is identified as a rapidly expanding pharmaceutical company based in India, where various dosage forms like tablets, capsules, and ampoules are manufactured and introduced to the market. Innovative products are developed to address unmet medical needs, with a focus on quality supply to enhance customer satisfaction. The companys vision emphasizes the preservation of human lives through effective medications, while goals involve offering prescription products that make a meaningful impact on healthcare. Efforts are directed towards launching new therapies to support the medical community.
KHK Pharma offers Tablets and Capsules.
KHK Pharma operates through Khk Pharmaceuticals Private Limited.
The legal entities of KHK Pharma currently have 3 directors, including Sohail Abbas, Nayeem Ahmad Siddiqui, Moiz Ahmad.